Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: Am J Hematol. 2017 Jun 9;92(9):845–850. doi: 10.1002/ajh.24782

Table 2.

Current status of MRD positive patients, N=17.

Continued Remission on HMA HMA Failure

N=12 (%) N=5 (%)
Morphologic Complete Remission 12 100% 5 100%
Cytogenetic Complete Remission 12 100% 5 100%
RTPCR at Initiation, median (range) 0.06
(0.01–0.91)
0.06
(0.01–3.84)
RTPCR Increase after initial 2 cycles HMA 1 8% 5 100%
RTPCR Decrease after initial 2 cycles HMA 11 92% 0 0%